Search a phrase in the box below (eg, “sample types” or “results”) or choose a question from the list below.
About the Oncoguard® Liver test
-
My doctor has ordered an Oncoguard® Liver test. What is it?
-
How is the Oncoguard® Liver test performed?
-
What do I need to do to prepare for the Oncoguard® Liver test?
-
How is the Oncoguard® Liver test different than other tests to detect liver cancer?
-
How well does the Oncoguard® Liver test perform?
-
I was assigned intersex at birth. Can I use the Oncoguard® Liver test?
-
Can I use the Oncoguard® Liver test if I am on hormone therapy for a gender transition?
Results
-
How do I get results of the test?
-
What does a high test result mean?
-
What does a negative test result mean?
-
What does an invalid test result mean?
-
What happens if I get an invalid test result?
Frequency
-
How often do I need to get the Oncoguard® Liver test?
-
I got a reminder that it is time for me to get tested for liver cancer. What should I do?
Insurance & Billing
-
Is the Oncoguard® Liver test covered by insurance?
-
How much will I have to pay for the Oncoguard® Liver test?
-
What if I can’t afford to pay for the Oncoguard® Liver test?
The term liver cancer is used to represent the most common form of liver cancer, hepatocellular carcinoma (HCC).
References: 1. Mayo Clinic Staff. Abdominal ultrasound https://www.mayoclinic.org/tests-procedures/abdominal-ultrasound/about/pac-20392738. Accessed April 18, 2024. 2. Simmons O, Fetzer DT, Yokoo T, et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45(1):169-177. 3. Chalasani NP, Porter K, Bhattacharya A, Book AJ, Neis BM, Xiong KM, Ramasubramanian TS, Edwards V DK, Chen I, Johnson S, Roberts LR, Kisiel JB, Reddy KR, Singal AG, Olson MC, Bruinsma JJ, Validation of a novel multi-target blood test shows high sensitivity to detect early-stage hepatocellular carcinoma, Clinical Gastroenterology and Hepatology (2021) 4. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget Stool DNA Testing for Colorectal-Cancer Screening. The New England Journal of Medicine. 2014;370(14):1287-1297.5. Habib ZA. Maternal serum alpha-feto-protein: its value in antenatal diagnosis of genetic disease and in obstetrical-gynaecological care. Acta Obstet Gynecol Scand Suppl. 1977;61:1-92.